AmSurg (AMSG) Reports In-Line Q3 EPS, FY Rev. Guidance Tops Consensus

November 1, 2016 4:28 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

AmSurg (NASDAQ: AMSG) reported Q3 EPS of $1.13, in-line with the analyst estimate of $1.13. Revenue for the quarter came in at $822.2 billion versus the consensus estimate of $770.29 million.

GUIDANCE:

AmSurg sees Q4 2016 EPS of $1.23, versus the consensus of $1.28.

AmSurg sees FY2016 EPS of $4.28-$4.33, versus the consensus of $4.33. AmSurg sees FY2016 revenue of $3.15-3.17 billion, versus the consensus of $3.08 billion.

For earnings history and earnings-related data on AmSurg (AMSG) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment